SF Healthcare Week: Flagship Pioneering's Founder Noubar Afeyan shares his thoughts on the image of science in the United States today, biotech's roller coaster 2025, mRNA, AI, and more
BiotechTV - News
00:00
State of biotech investing and market rebound
Noubar analyzes biotech's post-pandemic slump and rapid rebound, cautioning against over-optimistic valuations and predictions.
Play episode from 08:40
Transcript
